01

Computerized System Validation

We prove, with documented evidence, that your GxP system does what it should — consistently.

GAMP 521 CFR Part 11ANVISACSA

Computerized System Validation (CSV) proves, with documented evidence, that a GxP system operates consistently and per its intended use — protecting patient safety, product quality and data integrity.

Not every system needs validation: effort concentrates on GxP-relevant systems, those affecting product, quality, patient safety or data integrity. The GAMP category (1, 3, 4, 5) sets the depth of the lifecycle.

We adopt the risk-based approach of GAMP 5 (2nd edition) and the logic of Computer Software Assurance (CSA): more critical thinking and risk-driven testing, less paperwork with no value.

Deliverables cycle

URS & Initial Risk Assessment

The User Requirements Specification (URS) clearly and objectively defines everything the system must meet — drafted by a multidisciplinary team and approved by Quality Assurance. Alongside it, the initial risk assessment decides whether the system is GxP-relevant, and thereby the scope and depth of validation.

Validation Plan

Records the standards, methodology, team and release strategy across the lifecycle. Started at the earliest opportunity and revised at later stages; in agile approaches, it details release by sprints and configurations.

Specifications (FS/DS)

The functional specification clearly describes what the system does to meet the URS; the design specification details the infrastructure it runs on. Both are traced to each requirement and can be contractual documents between client and supplier.

IQ/OQ/PQ Protocols & Scripts

Protocols and scripts guiding installation, operation and performance testing, with scope, sampling, acceptance criteria and failure handling. Test rigor is proportional to GxP risk — more documented challenges where impact is greater.

Traceability Matrix

Links requirement, risk, specification and test evidence end to end. Ensures no requirement is orphaned, that each evidence points to a real need, and eases impact assessment of any future change.

Final Validation Report

Consolidates the results of all test phases and formally declares the validated state, per the Validation Plan strategy. From its approval, the system becomes subject to change control.

How we run it

01

Plan & assess risk

URS, GxP triage and validation plan.

02

Specify

FS/DS and traceability matrix.

03

Verify

Risk-driven IQ/OQ/PQ with deviation handling.

04

Release & maintain

Final report, validated state and change control.

Applicable standards

GAMP 5 (2nd ed.)ANVISAFDA 21 CFR Part 11EU Annex 11CSA

Frequently asked questions

Do I need to validate every system?

No. Only GxP-relevant systems — those affecting product, quality, patient safety or data integrity. We do the triage for you.

Do you work with supplier packages?

Yes. We review the manufacturer documentation and complete the remaining cycle to the validated state.

Does CSA replace CSV?

CSA is an evolution of CSV: more critical thinking and risk-focused testing. We apply both depending on the system.